9 Meters Biopharma Inc
(NMTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,977 | 356 | 174 | 39 | 150 |
| Receivables | N/A | 75 | 127 | 214 | 817 |
| Inventories | N/A | N/A | 498 | 607 | 638 |
| Other current assets | 0 | 160 | 0 | 0 | 0 |
| TOTAL | $13,228 | $752 | $1,056 | $1,185 | $2,026 |
| Non-Current Assets | |||||
| PPE Net | 52 | 41 | N/A | N/A | N/A |
| Intangibles | 0 | 0 | 2,319 | 2,351 | 2,384 |
| Other Non-Current Assets | 6 | 6 | 14 | 14 | 14 |
| TOTAL | $58 | $46 | $2,333 | $2,365 | $2,398 |
| Total Assets | $13,285 | $799 | $3,389 | $3,550 | $4,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 107 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,025 | 2,659 | 658 | 633 | 701 |
| Accrued Expenses | 6 | 1,180 | 1,506 | 1,416 | 1,473 |
| Other current liabilities | N/A | N/A | 1,336 | 1,336 | 1,225 |
| TOTAL | $5,439 | $12,973 | $4,877 | $3,763 | $3,437 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,439 | $12,973 | $4,877 | $3,763 | $3,437 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,285 | 1,285 | 47 | 47 | 42 |
| Common Shares | 3 | 12 | 1 | 1 | 1 |
| Retained earnings | -35,509 | -19,354 | -37,475 | -35,967 | -34,329 |
| TOTAL | $7,846 | $-12,175 | $-1,488 | $-213 | $987 |
| Total Liabilities And Equity | $13,285 | $799 | $3,389 | $3,550 | $4,424 |